Mass spectrometry is an analytic technique with high specificity and a growing presence in laboratory medicine. Various types of mass spectrometers are being used in an increasing number of clinical laboratories around the world, and, as a result, significant improvements in assay performance are occurring rapidly in areas such as toxicology, endocrinology, and biochemical genetics.

Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing.

The global production of the Clinical Mass Spectrometry is about 1931 units, North America is the largest production region, and the North America occupies about 63% of the market share. The second largest region is Europe, the region occupies about 25% market share, the Asia has little production, it only occupies about 10% market share in 2015. The largest company is Thermo Fisher, it occupies more than 26% of the market share, and the second largest company is AB Sciex (Danaher).

The largest consumption region is North America, it occupies about 46% market share in 2015, the second largest region is the Europe, it occupies about 32% market share, and the smallest consumption region is ROW, the consumption rate in China is about 6% in 2015.

In the last five years, the Clinical Mass Spectrometry has great consumption growth rate, it can be divided into two types LC-MS and GC-MS, the LC-MS occupies about 81% market share in 2015, in the application region, it mainly used in the Clinical Research, it occupies about 74% market share in 2015; In the future, the permeability will have high growth rate, the price have great relationship with the raw material and technology.

According to this study, over the next five years the Clinical Mass Spectrometry market will register a 6.2% CAGR in terms of revenue, the global market size will reach US$ 920 million by 2024, from US$ 640 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Clinical Mass Spectrometry business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Mass Spectrometry market by product type, application, key manufacturers and key regions and countries.

This study considers the Clinical Mass Spectrometry value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

LC-MS

GC-MS

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

Clinical Diagnostics

Clinical Research

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Thermo Fisher

AB Sciex (Danaher)

Waters

Agilent

Bruker

Perkin Elmer

Shidmazu

...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Clinical Mass Spectrometry consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Clinical Mass Spectrometry market by identifying its various subsegments.

Focuses on the key global Clinical Mass Spectrometry manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Clinical Mass Spectrometry with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Clinical Mass Spectrometry submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2019-2024 Global Clinical Mass Spectrometry Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Clinical Mass Spectrometry Consumption 2014-2024

2.1.2 Clinical Mass Spectrometry Consumption CAGR by Region

2.2 Clinical Mass Spectrometry Segment by Type

2.2.1 LC-MS

2.2.2 GC-MS

2.3 Clinical Mass Spectrometry Consumption by Type

2.3.1 Global Clinical Mass Spectrometry Consumption Market Share by Type (2014-2019)

2.3.2 Global Clinical Mass Spectrometry Revenue and Market Share by Type (2014-2019)

2.3.3 Global Clinical Mass Spectrometry Sale Price by Type (2014-2019)

2.4 Clinical Mass Spectrometry Segment by Application

2.4.1 Clinical Diagnostics

2.4.2 Clinical Research

2.5 Clinical Mass Spectrometry Consumption by Application

2.5.1 Global Clinical Mass Spectrometry Consumption Market Share by Application (2014-2019)

2.5.2 Global Clinical Mass Spectrometry Value and Market Share by Application (2014-2019)

2.5.3 Global Clinical Mass Spectrometry Sale Price by Application (2014-2019)

3 Global Clinical Mass Spectrometry by Players

3.1 Global Clinical Mass Spectrometry Sales Market Share by Players

3.1.1 Global Clinical Mass Spectrometry Sales by Players (2017-2019)

3.1.2 Global Clinical Mass Spectrometry Sales Market Share by Players (2017-2019)

3.2 Global Clinical Mass Spectrometry Revenue Market Share by Players

3.2.1 Global Clinical Mass Spectrometry Revenue by Players (2017-2019)

3.2.2 Global Clinical Mass Spectrometry Revenue Market Share by Players (2017-2019)

3.3 Global Clinical Mass Spectrometry Sale Price by Players

3.4 Global Clinical Mass Spectrometry Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Clinical Mass Spectrometry Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Clinical Mass Spectrometry Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Clinical Mass Spectrometry by Regions

4.1 Clinical Mass Spectrometry by Regions

4.1.1 Global Clinical Mass Spectrometry Consumption by Regions

4.1.2 Global Clinical Mass Spectrometry Value by Regions

4.2 Americas Clinical Mass Spectrometry Consumption Growth

4.3 APAC Clinical Mass Spectrometry Consumption Growth

4.4 Europe Clinical Mass Spectrometry Consumption Growth

4.5 Middle East & Africa Clinical Mass Spectrometry Consumption Growth

5 Americas

5.1 Americas Clinical Mass Spectrometry Consumption by Countries

5.1.1 Americas Clinical Mass Spectrometry Consumption by Countries (2014-2019)

5.1.2 Americas Clinical Mass Spectrometry Value by Countries (2014-2019)

5.2 Americas Clinical Mass Spectrometry Consumption by Type

5.3 Americas Clinical Mass Spectrometry Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Clinical Mass Spectrometry Consumption by Countries

6.1.1 APAC Clinical Mass Spectrometry Consumption by Countries (2014-2019)

6.1.2 APAC Clinical Mass Spectrometry Value by Countries (2014-2019)

6.2 APAC Clinical Mass Spectrometry Consumption by Type

6.3 APAC Clinical Mass Spectrometry Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Clinical Mass Spectrometry by Countries

7.1.1 Europe Clinical Mass Spectrometry Consumption by Countries (2014-2019)

7.1.2 Europe Clinical Mass Spectrometry Value by Countries (2014-2019)

7.2 Europe Clinical Mass Spectrometry Consumption by Type

7.3 Europe Clinical Mass Spectrometry Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Clinical Mass Spectrometry by Countries

8.1.1 Middle East & Africa Clinical Mass Spectrometry Consumption by Countries (2014-2019)

8.1.2 Middle East & Africa Clinical Mass Spectrometry Value by Countries (2014-2019)

8.2 Middle East & Africa Clinical Mass Spectrometry Consumption by Type

8.3 Middle East & Africa Clinical Mass Spectrometry Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Clinical Mass Spectrometry Distributors

10.3 Clinical Mass Spectrometry Customer

11 Global Clinical Mass Spectrometry Market Forecast

11.1 Global Clinical Mass Spectrometry Consumption Forecast (2019-2024)

11.2 Global Clinical Mass Spectrometry Forecast by Regions

11.2.1 Global Clinical Mass Spectrometry Forecast by Regions (2019-2024)

11.2.2 Global Clinical Mass Spectrometry Value Forecast by Regions (2019-2024)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Clinical Mass Spectrometry Forecast by Type

11.8 Global Clinical Mass Spectrometry Forecast by Application

12 Key Players Analysis

12.1 Thermo Fisher

12.1.1 Company Details

12.1.2 Clinical Mass Spectrometry Product Offered

12.1.3 Thermo Fisher Clinical Mass Spectrometry Sales, Revenue, Price and Gross Margin (2017-2019)

12.1.4 Main Business Overview

12.1.5 Thermo Fisher News

12.2 AB Sciex (Danaher)

12.2.1 Company Details

12.2.2 Clinical Mass Spectrometry Product Offered

12.2.3 AB Sciex (Danaher) Clinical Mass Spectrometry Sales, Revenue, Price and Gross Margin (2017-2019)

12.2.4 Main Business Overview

12.2.5 AB Sciex (Danaher) News

12.3 Waters

12.3.1 Company Details

12.3.2 Clinical Mass Spectrometry Product Offered

12.3.3 Waters Clinical Mass Spectrometry Sales, Revenue, Price and Gross Margin (2017-2019)

12.3.4 Main Business Overview

12.3.5 Waters News

12.4 Agilent

12.4.1 Company Details

12.4.2 Clinical Mass Spectrometry Product Offered

12.4.3 Agilent Clinical Mass Spectrometry Sales, Revenue, Price and Gross Margin (2017-2019)

12.4.4 Main Business Overview

12.4.5 Agilent News

12.5 Bruker

12.5.1 Company Details

12.5.2 Clinical Mass Spectrometry Product Offered

12.5.3 Bruker Clinical Mass Spectrometry Sales, Revenue, Price and Gross Margin (2017-2019)

12.5.4 Main Business Overview

12.5.5 Bruker News

12.6 Perkin Elmer

12.6.1 Company Details

12.6.2 Clinical Mass Spectrometry Product Offered

12.6.3 Perkin Elmer Clinical Mass Spectrometry Sales, Revenue, Price and Gross Margin (2017-2019)

12.6.4 Main Business Overview

12.6.5 Perkin Elmer News

12.7 Shidmazu

12.7.1 Company Details

12.7.2 Clinical Mass Spectrometry Product Offered

12.7.3 Shidmazu Clinical Mass Spectrometry Sales, Revenue, Price and Gross Margin (2017-2019)

12.7.4 Main Business Overview

12.7.5 Shidmazu News

...

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Clinical Mass Spectrometry

Table Product Specifications of Clinical Mass Spectrometry

Figure Clinical Mass Spectrometry Report Years Considere